Page last updated: 2024-11-05

ici 204,219 and Hepatitis B Virus Infection

ici 204,219 has been researched along with Hepatitis B Virus Infection in 3 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Zhao, S1
Zhen, Y1
Fu, L2
Gao, F1
Zhou, X1
Huang, S1
Zhang, L2
Chen, S1
Chen, Y1
Donkers, JM1
Zehnder, B1
van Westen, GJP1
Kwakkenbos, MJ1
IJzerman, AP1
Oude Elferink, RPJ1
Beuers, U1
Urban, S1
van de Graaf, SFJ1

Reviews

1 review available for ici 204,219 and Hepatitis B Virus Infection

ArticleYear
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
    Journal of medicinal chemistry, 2022, 10-13, Volume: 65, Issue:19

    Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interf

2022

Other Studies

2 other studies available for ici 204,219 and Hepatitis B Virus Infection

ArticleYear
Design, synthesis and biological evaluation of benzamide derivatives as novel NTCP inhibitors that induce apoptosis in HepG2 cells.
    Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19

    Topics: Antineoplastic Agents; Antiviral Agents; Apoptosis; Benzamides; Drug Design; Hep G2 Cells; Hepatitis

2019
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.
    Scientific reports, 2017, 11-10, Volume: 7, Issue:1

    Topics: Animals; Antiviral Agents; Dogs; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus;

2017